Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Susan Smith, a professor of nutritional sciences at the University of Wisconsin-Madison, has received a prestigious MERIT award from the National Institutes of Health
In a study that demonstrates the promise of cell-based therapies for diseases that have proved intractable to modern medicine, a team of scientists from the University of Wisconsin-Madison has shown it is possible to rescue the dying neurons characteristic of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disorder also known as Lou Gehrig's disease.
By Dave Tenenbaum, University Communications For hundreds of years, Tibetan monks and other religious people have used meditation to calm the mind and improve concentration. This week, a new study shows exactly how one common type of meditation affects the brain. Using a scanner that reveals which parts of the brain are active at any …
In an effort to strengthen and sustain its leadership in the companion fields of stem cell research and regenerative medicine, the University of Wisconsin-Madison will establish a new Stem Cell and Regenerative Medicine Center.
Everyday experience and psychology research both indicate that paying close attention to one thing can keep you from noticing something else.
Infant Learning Lab researchers have recently focused on learning more about people with delayed language comprehension by observing learning methods used by children developing normally and children experiencing language delays.
A child's first word is a special moment, their eyes widening in curiosity, one chubby finger pointing to an object in sudden recognition as "juice" or "train."
Researchers funded by the National Institutes of Health have discovered how a defect in a single master gene disrupts the process by which several genes interact to create myelin, a fatty coating that covers nerve cells and increases the speed and reliability of their electrical signals.
For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue. In a study in rats, neural progenitor cells derived from human fetal stem cells have been shown to protect the vision of animals with degenerative eye disease similar to the kinds of diseases that afflict humans.
CytoDyn, Inc. has selected the Waisman Clinical BioManufacturing Facility at the University of Wisconsin at Madison to manufacture the Company’s DNA-based pre-flu vaccine. CytoDyn’s pre-flu vaccine provides an alternative approach to immunization that could make flu vaccines for the seasonal flu and bird flu more effective. It uses DNA technology to implant a false memory …
